Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma
Susanna Leskelä, Belén Perez‐Mies, Juan Manuel Rosa-Rosa, et al.
Cancers (2019) Vol. 11, Iss. 7, pp. 964-964
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Endometrial cancer
Vicky Makker, Helen Mackay, Isabelle Ray‐Coquard, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 371
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
Matthew A. Powell, Virginia L. Filiaci, Martee L. Hensley, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 9, pp. 968-977
Open Access | Times Cited: 72
Exosomes in Cancer: Diagnostic and Therapeutic Applications
Quratulain Maqsood, Aleena Sumrin, Yasar Saleem, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access | Times Cited: 17
Prognostic significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in uterine carcinosarcoma
Azusa Sakurai, Ken Yamaguchi, Kentaro Ishida, et al.
International Journal of Clinical Oncology (2025)
Closed Access | Times Cited: 2
Exosomes as Biomarkers for Female Reproductive Diseases Diagnosis and Therapy
Sahar Esfandyari, Hoda Elkafas, Rishi Man Chugh, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2165-2165
Open Access | Times Cited: 102
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence
Yue Zhao, Ziwei Pan, Sandeep Namburi, et al.
EBioMedicine (2020) Vol. 61, pp. 103030-103030
Open Access | Times Cited: 100
Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity
Shinya Matsuzaki, Maximilian Klar, Satoko Matsuzaki, et al.
Gynecologic Oncology (2020) Vol. 160, Iss. 2, pp. 586-601
Closed Access | Times Cited: 89
TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma
Antonio Travaglino, Antonio Raffone, Annarita Gencarelli, et al.
Pathology & Oncology Research (2020) Vol. 26, Iss. 4, pp. 2067-2073
Closed Access | Times Cited: 78
Vasculogenic mimicry, a complex and devious process favoring tumorigenesis – Interest in making it a therapeutic target
Lucas Treps, Sébastien Faure, Nicolas Clere
Pharmacology & Therapeutics (2021) Vol. 223, pp. 107805-107805
Open Access | Times Cited: 66
PTEN Dual Lipid- and Protein-Phosphatase Function in Tumor Progression
Anne Liu, Yan‐Yu Zhu, Weiping Chen, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3666-3666
Open Access | Times Cited: 43
Endometrial Cancer Cells Promote M2-Like Macrophage Polarization by Delivering Exosomal miRNA-21 under Hypoxia Condition
Li Xiao, Yumin He, Fan Peng, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-9
Open Access | Times Cited: 63
A Systematic Review of PET Textural Analysis and Radiomics in Cancer
Manuel Piñeiro-Fiel, Alexis Moscoso, Virginia Pubul, et al.
Diagnostics (2021) Vol. 11, Iss. 2, pp. 380-380
Open Access | Times Cited: 48
Uterine carcinosarcoma: An overview
Gaetano Pezzicoli, Francesca Moscaritolo, Erica Silvestris, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 163, pp. 103369-103369
Closed Access | Times Cited: 39
The lncRNA GAS5 Inhibits the Osteogenic Differentiation and Calcification of Human Vascular Smooth Muscle Cells
Zhihui Chang, Guangxin Yan, Jiahe Zheng, et al.
Calcified Tissue International (2020) Vol. 107, Iss. 1, pp. 86-95
Closed Access | Times Cited: 39
A PoleP286R mouse model of endometrial cancer recapitulates high mutational burden and immunotherapy response
Hao‐Dong Li, Changzheng Lu, He Zhang, et al.
JCI Insight (2020) Vol. 5, Iss. 14
Open Access | Times Cited: 33
Construction of a miRNA-Based Nomogram Model to Predict the Prognosis of Endometrial Cancer
Leyi Ni, Chengyun Tang, Yuning Wang, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1154-1154
Open Access | Times Cited: 22
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
Lea A. Moukarzel, Lorenzo Ferrando, Arnaud Da Cruz Paula, et al.
Molecular Oncology (2020) Vol. 15, Iss. 4, pp. 1024-1039
Open Access | Times Cited: 32
Uterine carcinosarcoma with heterologous osseous elements: a case report of an extremely rare clinical occurrence with literature review
Hiba A. Al Dallal, Taylor H. Jacobs, Cody Bergman, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Onvansertib exhibits anti-proliferative and anti-invasive effects in endometrial cancer
Nikita Sinha, Xiaochang Shen, Jennifer Haag, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Unconventional success: Achieving long-term remission with pembrolizumab in recurrent high-grade endometrial carcinosarcoma
Anaiya Singh, Viraj Panchal, Suvarna Guvvala, et al.
Gynecologic Oncology Reports (2025) Vol. 59, pp. 101748-101748
Open Access
Circ_0007331 knock‐down suppresses the progression of endometriosis via miR‐200c‐3p/HiF‐1α axis
Lan Dong, Lu Zhang, Hua Liu, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 21, pp. 12656-12666
Open Access | Times Cited: 25
Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma
Silvia González-Martínez, Belén Perez‐Mies, David Pizarro, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7398-7398
Open Access | Times Cited: 23
MLLT11-TRIL complex promotes the progression of endometrial cancer through PI3K/AKT/mTOR signaling pathway
Jingnan Liao, Huan Chen, Mingming Qi, et al.
Cancer Biology & Therapy (2022) Vol. 23, Iss. 1, pp. 211-224
Open Access | Times Cited: 16
Downregulation of ATP5F1D inhibits mtROS/NLRP3/caspase-1/GSDMD axis to suppress pyroptosis-mediated malignant progression of endometrial cancer
Yuemei Cheng, Xi Chen, Dan Hu, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112808-112808
Closed Access | Times Cited: 3
Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival
Christine Rojas, Chunqiao Tian, Matthew A. Powell, et al.
Gynecologic Oncology (2020) Vol. 157, Iss. 1, pp. 67-77
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top